| 1 | The Cancer Stem Cell Niche in Ovarian Cancer and Its Impact on Immune Surveillance. 2021;22:4091 doi: 10.3390/ijms22084091 |
| 2 | Proteomimetics of Natural Regulators of JAK–STAT Pathway: Novel Therapeutic Perspectives. 2022;8: doi: 10.3389/fmolb.2021.792546 |
| 3 | Functional Analysis of Non-Genetic Resistance to Platinum in Epithelial Ovarian Cancer Reveals a Role for the MBD3-NuRD Complex in Resistance Development. 2021;13:3801 doi: 10.3390/cancers13153801 |
| 4 | Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications. 2021;22:3805 doi: 10.3390/ijms22083805 |
| 5 | Single-cell transcriptional profiling reveals heterogeneity and developmental trajectories of Ewing sarcoma. 2022;148:3267 doi: 10.1007/s00432-022-04073-3 |
| 6 | The JAK/STAT signaling pathway: from bench to clinic. 2021;6: doi: 10.1038/s41392-021-00791-1 |
| 7 | JAK2-Mediated Phosphorylation of Stress-Induced Phosphoprotein-1 (STIP1) in Human Cells. 2022;23:2420 doi: 10.3390/ijms23052420 |
| 8 | Cancer Stem Cell (CSC) Inhibitors in Oncology—A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives. 2020;63:15279 doi: 10.1021/acs.jmedchem.0c01336 |
| 9 | Rational Combinations of Targeted Therapy and Immune Checkpoint Inhibitors in Head and Neck Cancers. 2022;12: doi: 10.3389/fonc.2022.837835 |
| 10 | The Growth Inhibitory Effect on B16F10 Melanoma Cells by 4-BPCA, an Amide Derivative of Caffeic Acid. 2022;41:17 doi: 10.46308/kmj.2022.00066 |
| 11 | Cancer stem cell markers interplay with chemoresistance in triple negative breast cancer: A therapeutic perspective. 2022;109:960 doi: 10.1016/j.bulcan.2022.05.007 |
| 12 | Cancer Stem Cells in Tumor Microenvironment of Adenocarcinoma of the Stomach, Colon, and Rectum. 2022;14:3948 doi: 10.3390/cancers14163948 |
| 13 | A miR-129-5P/ARID3A Negative Feedback Loop Modulates Diffuse Large B Cell Lymphoma Progression and Immune Evasion Through Regulating the PD-1/PD-L1 Checkpoint. 2021;9: doi: 10.3389/fcell.2021.735855 |
| 14 | JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies. 2022;13: doi: 10.3389/fphar.2022.821344 |
| 15 | IL4Rα and IL13Rα1 Are Involved in the Development of Human Gallbladder Cancer. 2022;12:249 doi: 10.3390/jpm12020249 |
| 16 | Targeting protein kinases in cancer stem cells. 2022;66:399 doi: 10.1042/EBC20220002 |
| 17 | TYK2 in Cancer Metastases: Genomic and Proteomic Discovery. 2021;13:4171 doi: 10.3390/cancers13164171 |
| 18 | Mechanisms of Cancer Cell Death: Therapeutic Implications for Pancreatic Ductal Adenocarcinoma. 2021;13:4834 doi: 10.3390/cancers13194834 |
| 19 | Genomic Mutations of the STAT5 Transcription Factor Are Associated with Human Cancer and Immune Diseases. 2022;23:11297 doi: 10.3390/ijms231911297 |
| 20 | Bridging Radiotherapy to Immunotherapy: The IFN–JAK–STAT Axis. 2021;22:12295 doi: 10.3390/ijms222212295 |
| 21 | Novel Perspectives in Pseudomyxoma Peritonei Treatment. 2021;13:5965 doi: 10.3390/cancers13235965 |
Journal of Cancer Metastasis and Treatment
